169 related articles for article (PubMed ID: 35511473)
1. DNA methylation subclass receptor tyrosine kinase II (RTK II) is predictive for seizure development in glioblastoma patients.
Ricklefs FL; Drexler R; Wollmann K; Eckhardt A; Heiland DH; Sauvigny T; Maire C; Lamszus K; Westphal M; Schüller U; Dührsen L
Neuro Oncol; 2022 Nov; 24(11):1886-1897. PubMed ID: 35511473
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.
Drexler R; Schüller U; Eckhardt A; Filipski K; Hartung TI; Harter PN; Divé I; Forster MT; Czabanka M; Jelgersma C; Onken J; Vajkoczy P; Capper D; Siewert C; Sauvigny T; Lamszus K; Westphal M; Dührsen L; Ricklefs FL
Neuro Oncol; 2023 Feb; 25(2):315-325. PubMed ID: 35868257
[TBL] [Abstract][Full Text] [Related]
3. Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes.
Kessler T; Berberich A; Sadik A; Sahm F; Gorlia T; Meisner C; Hoffmann DC; Wick A; Kickingereder P; Rübmann P; Bendszus M; Opitz C; Weller M; van den Bent M; Stupp R; Winkler F; Brandes A; von Deimling A; Platten M; Wick W
Cancer Med; 2020 Nov; 9(22):8373-8385. PubMed ID: 32991787
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival.
Dejaegher J; Solie L; Hunin Z; Sciot R; Capper D; Siewert C; Van Cauter S; Wilms G; van Loon J; Ectors N; Fieuws S; Pfister SM; Van Gool SW; De Vleeschouwer S
Neuro Oncol; 2021 Feb; 23(2):240-250. PubMed ID: 33130898
[TBL] [Abstract][Full Text] [Related]
6. Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma.
Liu EK; Vasudevaraja V; Sviderskiy VO; Feng Y; Tran I; Serrano J; Cordova C; Kurz SC; Golfinos JG; Sulman EP; Orringer DA; Placantonakis D; Possemato R; Snuderl M
Neurooncol Adv; 2022; 4(1):vdac163. PubMed ID: 36382106
[TBL] [Abstract][Full Text] [Related]
7. Seizure-susceptible brain regions in glioblastoma: identification of patients at risk.
Cayuela N; Simó M; Majós C; Rifà-Ros X; Gállego Pérez-Larraya J; Ripollés P; Vidal N; Miró J; Gil F; Gil-Gil M; Plans G; Graus F; Bruna J
Eur J Neurol; 2018 Feb; 25(2):387-394. PubMed ID: 29115706
[TBL] [Abstract][Full Text] [Related]
8. Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma.
Wick A; Kessler T; Platten M; Meisner C; Bamberg M; Herrlinger U; Felsberg J; Weyerbrock A; Papsdorf K; Steinbach JP; Sabel M; Vesper J; Debus J; Meixensberger J; Ketter R; Hertler C; Mayer-Steinacker R; Weisang S; Bölting H; Reuss D; Reifenberger G; Sahm F; von Deimling A; Weller M; Wick W
Neuro Oncol; 2020 Aug; 22(8):1162-1172. PubMed ID: 32064499
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the Receptor Tyrosine Kinase AXL in Response to Therapy and Its Role in Therapy Resistance in Glioblastoma.
Scherschinski L; Prem M; Kremenetskaia I; Tinhofer I; Vajkoczy P; Karbe AG; Onken JS
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055167
[TBL] [Abstract][Full Text] [Related]
10. Molecular landscape of IDH-wild-type, H3-wild-type glioblastomas of adolescents and young adults.
Shi ZF; Li KK; Huang QJ; Wang WW; Kwan JS; Chen H; Liu XZ; Li WC; Chan DT; Zhang ZY; Mao Y; Ng HK
Neuropathol Appl Neurobiol; 2022 Jun; 48(4):e12802. PubMed ID: 35191072
[TBL] [Abstract][Full Text] [Related]
11. An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.
Sintupisut N; Liu PL; Yeang CH
Nucleic Acids Res; 2013 Oct; 41(19):8803-21. PubMed ID: 23907387
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for preoperative and postoperative seizures in patients with glioblastoma according to the 2021 World Health Organization classification.
Feyissa AM; Sanchez-Boluarte SS; Moniz-Garcia D; Chaichana KL; Sherman WJ; Freund BE; Tatum WO; Middlebrooks EH; Sirven JI; Quinones-Hinojosa A
Seizure; 2023 Nov; 112():26-31. PubMed ID: 37729723
[TBL] [Abstract][Full Text] [Related]
13. Potential influence of IDH1 mutation and MGMT gene promoter methylation on glioma-related preoperative seizures and postoperative seizure control.
Feyissa AM; Worrell GA; Tatum WO; Chaichana KL; Jentoft ME; Guerrero Cazares H; Ertekin-Taner N; Rosenfeld SS; ReFaey K; Quinones-Hinojosa A
Seizure; 2019 Jul; 69():283-289. PubMed ID: 31141785
[TBL] [Abstract][Full Text] [Related]
14. Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme.
Telfeian AE; Philips MF; Crino PB; Judy KD
J Exp Clin Cancer Res; 2001 Mar; 20(1):5-10. PubMed ID: 11370829
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates.
Kastenhuber ER; Huse JT; Berman SH; Pedraza A; Zhang J; Suehara Y; Viale A; Cavatore M; Heguy A; Szerlip N; Ladanyi M; Brennan CW
Acta Neuropathol; 2014 May; 127(5):747-59. PubMed ID: 24292886
[TBL] [Abstract][Full Text] [Related]
16. Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.
Drexler R; Khatri R; Schüller U; Eckhardt A; Ryba A; Sauvigny T; Dührsen L; Mohme M; Ricklefs T; Bode H; Hausmann F; Huber TB; Bonn S; Voß H; Neumann JE; Silverbush D; Hovestadt V; Suvà ML; Lamszus K; Gempt J; Westphal M; Heiland DH; Hänzelmann S; Ricklefs FL
Acta Neuropathol; 2024 Jan; 147(1):21. PubMed ID: 38244080
[TBL] [Abstract][Full Text] [Related]
17. Validation of a methylation-based signature for subventricular zone involvement in glioblastoma.
Ehret F; Zühlke O; Schweizer L; Kahn J; Csapo-Schmidt C; Roohani S; Zips D; Capper D; Adeberg S; Abdollahi A; Knoll M; Kaul D
J Neurooncol; 2024 Mar; 167(1):89-97. PubMed ID: 38376766
[TBL] [Abstract][Full Text] [Related]
18. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
[TBL] [Abstract][Full Text] [Related]
19. The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.
Pillay V; Allaf L; Wilding AL; Donoghue JF; Court NW; Greenall SA; Scott AM; Johns TG
Neoplasia; 2009 May; 11(5):448-58, 2 p following 458. PubMed ID: 19412429
[TBL] [Abstract][Full Text] [Related]
20. Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients.
Cucchiara F; Luci G; Giannini N; Giorgi FS; Orlandi P; Banchi M; Di Paolo A; Pasqualetti F; Danesi R; Bocci G
Pharmacol Res; 2022 Jul; 181():106290. PubMed ID: 35680010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
